Zera Health Review

What Zera Health charges

• Sermorelin: $155/mo — MONTHLY plan, "$155/mo — 3mg/6mg vial — billed monthly"; the same block prints a QUARTERLY column at "$130/mo — billed every 3 months", which is the seller’s own division of a quarterly total, and the hero prints a struck first-month offer, "From $125 $225 /first mo."
• NAD+: $130/mo — MONTHLY plan, "$130/mo — 250mg vial — billed monthly"; the same block prints a QUARTERLY column at "$110/mo — billed every 3 months", which is the seller’s own division of a quarterly total, and the hero prints a struck first-month offer, "From $99 $179 /first mo."
• Glutathione: $124/mo — MONTHLY plan, "$124/mo — 100mg/mL nasal spray — billed monthly"; the same block prints a QUARTERLY column at "$99/mo — billed every 3 months", which is the seller’s own division of a quarterly total, and the hero prints a struck first-month offer, "From $94 $179 /first mo."

The pharmacy is named, with its own web address

The footer disclaimer on every treatment page names the compounding pharmacy, calls it a licensed 503A facility and prints its web address.

That is a checkable fact. A reader can look the facility up, which is the entire point of asking whether a seller names one.

Most sellers compared here answer this question with a category — accredited pharmacies, state-licensed pharmacies, a facility described by its state and its accreditations — and a category cannot be looked up.

The same disclaimer also says plainly that the company is a technology platform rather than a medical services provider, which is a useful thing to state before an intake rather than after one.

Two plans, side by side, with the billing cycle written into each

Every treatment page prints a monthly column and a quarterly column next to each other, and each column states its own billing cycle in words underneath the figure.

The quarterly column's per-month figure is lower, and it is the seller's own division of a quarterly total rather than a charge anybody makes monthly.

This row stores the billed monthly figure and keeps the quarterly per-month figure in the qualifier beside it, so a later reader cannot quietly correct one into the other.

The hero on each page adds a struck-through first-month offer, which is a promotion rather than a rate anyone keeps paying, and it is recorded the same way.

A marquee that says fifty and an answer that does not

A scrolling banner on the site prints a fifty-state line, and it is a line about who holds licences rather than about where the company sells.

The FAQ answers the state question directly and says the company operates in most states, with availability varying by treatment type.

Those two sentences cannot both be the coverage fact, and the one that describes the company rather than its clinicians is the one this site records.

No list of the states actually served is published anywhere, so this row stores none and the marquee is recorded as the conflict it is.

One advertised treatment path renders the homepage instead

The sitemap lists a treatment page for one of the three compounds sold here. That URL answers successfully and lays out the GLP-1 homepage — no compound, no plan block.

The real page for that compound is the nasal preparation, which does carry a plan block, and that is what this row cites.

A reader who trusted the sitemap path would have concluded either that the compound is unpriced or, worse, that the weight-loss figure on the homepage is its price.

The host itself is not the problem: two nonsense paths rendered a genuine not-found document in the same pass, so this is one page behaving oddly rather than a host that answers everything.

How we verified this

• Rendered every treatment page in a browser and read the plan blocks as laid-out text.
• Recorded the billed monthly figure and kept the quarterly per-month figure in the qualifier, because the latter is the seller's own division of a quarterly total rather than a charge.
• Recorded the struck-through first-month offer as a promotion rather than storing it as the rate.
• Rendered the sitemap path for the third compound, found it serves the homepage, and cited the nasal preparation page that actually carries a plan block.
• Fired two nonsense paths at this host in the same pass and confirmed both render a genuine not-found document, so the odd path is one page rather than the host.
• Opened the FAQ's collapsed answers one at a time and read the state answer in full.
• Separated the banner's licensure line from the FAQ's company-level answer and set the coverage flag on the company's own sentence, then recorded the conflict rather than resolving it away.
• Read the third-party testing line in its own context and found it describes testing of the product rather than lab work for the patient, so it does not set the labs flag.
• Read the footer disclaimer on more than one page to confirm the pharmacy name appears sitewide rather than on a single template.
• Screened this seller in the live federal warning-letter record by brand, with a known-good positive control and a nonsense negative control fired in the same run, reading the company column rather than accepting a full-text match.